SEC Filings

SEC Filings

Filing date Description Form Filing Group Issuer View
View HTML

Termination of registration under Section 12(g) or suspension of duty to file reports

15-12B
Other
Eidos Therapeutics, Inc.
View HTML

25-NSE

25-NSE
Other
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.

Data provided by Kaleidoscope.